Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with ...

Crisis pregnancy centers — faux health clinics designed to deter pregnant people from getting abortions — are back at the ...

Former CDC official Demetre Daskalakis is taking his skills back to New York, where they were honed in HIV clinics and the ...

Good morning. I hope you’re having a better morning than this raccoon. Let’s get into the news today.

As hospitals study the impact of AI scribes, they are finding that clinicians love the tools, even if they don’t save that ...

Retro Bio, a longevity startup backed by OpenAI CEO Sam Altman, is close to raising what could be one of the drug industry’s ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...

ACIP has drifted toward inflating speculative risks while downplaying well-established vaccine benefits,” write former CDC ...

Bristol Myers Squibb will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer's disease.

CDC experts and manufacturers haven't been consulted for an ACIP review of hepatitis B vaccine, raising concerns over any ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

The American Hospital Association and several hospital systems have filed a lawsuit against the Trump administration, seeking ...